OKUR · ISSUER CIK 1637715
OnKure Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 OnKure Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $1K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1KInsider selling
−$1KNet open-market
Sep 23, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 202616:54 | Sep 21, 2026 | OKUR | President and CEO, Director | S · Sell | $2.97 | −87 | 11,160 | -1% | −$258.76 | ||
| Sep 23, 202616:52 | Sep 21, 2026 | OKUR | Chief Financial Officer | S · Sell | $2.97 | −302 | 18,500 | -2% | −$898.21 |